letrozole has been researched along with Abortion, Spontaneous in 28 studies
Abortion, Spontaneous: Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole-induced ovulation can obtain ovulation rate and pregnancy rate similar to gonadotropin, but reduce the risk associated with treatment." | 9.34 | Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. ( Chen, L; Hong, T; Huang, X; Jiang, F; Shi, S; Zhuang, Y, 2020) |
| " We have designed a multicenter randomized controlled trial (RCT) to evaluate whether personalized or fixed acupuncture increases the likelihood of live births in infertile women with polycystic ovary syndrome (PCOS) compared with letrozole or placebo letrozole." | 9.34 | A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome. ( Gao, X; Hu, M; Hu, R; Hu, Z; Huang, S; Lai, M; Li, J; Li, S; Liang, X; Liu, J; Ma, H; Ng, EHY; Qiao, J; Quan, K; Shang, H; Stener-Victorin, E; Wang, C; Wang, X; Wen, Q; Wen, X; Xia, T; Zheng, Y, 2020) |
| "Letrozole appears to improve live birth rates and pregnancy rates in infertile women with anovulatory PCOS, compared to SERMs, when used for ovulation induction, followed by intercourse." | 9.22 | Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. ( Farquhar, C; Franik, S; Kiesel, L; Kremer, JA; Le, QK, 2022) |
| "Letrozole appears to improve live birth and pregnancy rates in subfertile women with anovulatory polycystic ovary syndrome, compared to clomiphene citrate." | 8.98 | Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. ( Eltrop, SM; Farquhar, C; Franik, S; Kiesel, L; Kremer, JA, 2018) |
| "No studies have been conducted on the impact of different types of ovulatory dysfunction on the outcomes of frozen-thawed embryo transfers (FETs) in a letrozole-stimulated cycle in women with polycystic ovarian syndrome (PCOS)." | 8.31 | Comparison of pregnancy outcomes of letrozole-induced frozen-thawed embryo transfer cycles in PCOS women with two different abnormal ovulation patterns: A retrospective cohort study. ( Cao, JX; Hou, JW; Jiang, WJ; Song, JY; Sun, ZG; Wang, DD; Yan, MH, 2023) |
| "These results suggest that letrozole use may improve clinical pregnancy, clinical pregnancy with fetal heart beat, and live births and reduce the risk of miscarriage in patients undergoing single FET cycles." | 7.85 | Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles. ( Irahara, M; Jwa, SC; Kubota, T; Kuwahara, A; Saito, H; Tatsumi, T, 2017) |
| "Letrozole (LE) has been found to improve the luteal function." | 5.91 | The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles. ( Chen, L; Gao, Y; Jiang, S; Kuang, Y; Long, H; Wang, Y; Xi, Q, 2023) |
| "8." | 5.91 | Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study. ( Cai, S; Gong, F; Guo, H; Li, X; Li, Y; Lin, G; Ma, S; Peng, Y; Tan, H; Tang, Y; Wang, X; Zhang, S, 2023) |
| "To evaluate the effectiveness and safety of IVF versus expectant management, unstimulated intrauterine insemination (IUI), and IUI with ovarian stimulation using gonadotropins, clomiphene citrate (CC), or letrozole in improving pregnancy outcomes." | 5.41 | In vitro fertilisation for unexplained subfertility. ( Bhattacharya, S; Gibreel, A; Kamath, MS; Pandian, Z; Sunkara, SK, 2023) |
| "Letrozole-induced ovulation can obtain ovulation rate and pregnancy rate similar to gonadotropin, but reduce the risk associated with treatment." | 5.34 | Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study. ( Chen, L; Hong, T; Huang, X; Jiang, F; Shi, S; Zhuang, Y, 2020) |
| " We have designed a multicenter randomized controlled trial (RCT) to evaluate whether personalized or fixed acupuncture increases the likelihood of live births in infertile women with polycystic ovary syndrome (PCOS) compared with letrozole or placebo letrozole." | 5.34 | A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome. ( Gao, X; Hu, M; Hu, R; Hu, Z; Huang, S; Lai, M; Li, J; Li, S; Liang, X; Liu, J; Ma, H; Ng, EHY; Qiao, J; Quan, K; Shang, H; Stener-Victorin, E; Wang, C; Wang, X; Wen, Q; Wen, X; Xia, T; Zheng, Y, 2020) |
| "Letrozole appears to improve live birth rates and pregnancy rates in infertile women with anovulatory PCOS, compared to SERMs, when used for ovulation induction, followed by intercourse." | 5.22 | Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. ( Farquhar, C; Franik, S; Kiesel, L; Kremer, JA; Le, QK, 2022) |
| "Ovulation induction with letrozole during endometrial preparation for FET has a higher rate of pregnancy success and a lower abortion rate than HRT." | 5.19 | Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer. ( Chai, XS; Chen, JL; Li, SJ; Nie, MF; Tao, GS; Zhang, YJ; Zhou, YY, 2014) |
| "Superovulation and IUI with letrozole and CC are associated with similar pregnancy rates, but the miscarriage rate is higher with CC." | 5.11 | A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. ( Al-Fozan, H; Al-Khadouri, M; Tan, SL; Tulandi, T, 2004) |
| "In analysis per patient, there was no significant difference in positive pregnancy test between patients treated with letrozole compared with clomiphene citrate (24% vs 23%, pooled RR 1." | 5.01 | Letrozole Compared With Clomiphene Citrate for Unexplained Infertility: A Systematic Review and Meta-analysis. ( Bedrick, BS; Colditz, GA; Eskew, AM; Hardi, A; Jungheim, ES; Stoll, CRT; Tuuli, MG, 2019) |
| "Letrozole appears to improve live birth and pregnancy rates in subfertile women with anovulatory polycystic ovary syndrome, compared to clomiphene citrate." | 4.98 | Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. ( Eltrop, SM; Farquhar, C; Franik, S; Kiesel, L; Kremer, JA, 2018) |
| "The objective of this study is to investigate and compare the effectiveness of letrozole and clomiphene citrate for improving fertility outcomes, including pregnancy rate, miscarriage rate, multiple pregnancy rate, and incidence rate of adverse events, number of dominant follicles, endometrial thickness at hCG day and serum E2 on hCG day." | 4.90 | Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis. ( Chen, W; Lang, J; Liu, A; Zheng, C, 2014) |
| " The Pregnancy in PCOS trial II will determine the safety and efficacy of clomiphene citrate compared to letrozole, in achieving live birth in infertile women with PCOS." | 4.88 | Reproductive impact of polycystic ovary syndrome. ( Legro, RS; Usadi, RS, 2012) |
| "No studies have been conducted on the impact of different types of ovulatory dysfunction on the outcomes of frozen-thawed embryo transfers (FETs) in a letrozole-stimulated cycle in women with polycystic ovarian syndrome (PCOS)." | 4.31 | Comparison of pregnancy outcomes of letrozole-induced frozen-thawed embryo transfer cycles in PCOS women with two different abnormal ovulation patterns: A retrospective cohort study. ( Cao, JX; Hou, JW; Jiang, WJ; Song, JY; Sun, ZG; Wang, DD; Yan, MH, 2023) |
| "Ovulation induction regimen with letrozole or hMG for endometrial preparation was associated with a higher livebirth rate and a lower pregnancy loss rate in frozen single-blastocyst transfer cycles among women with PCOS." | 4.12 | Ovulation induction regimens are associated with a higher rate of livebirth after frozen single-blastocyst transfer among women with polycystic ovary syndrome. ( Niu, Y; Suo, L; Wang, Y; Wei, D; Zhao, D; Zou, J, 2022) |
| "The objective of this study was to examine the pregnancy outcomes from frozen embryo transfer (FET) cycles using different endometrial preparation regimens, compared to ovulation induction with letrozole (letrozole OI)." | 4.02 | Retrospective cohort study on preparation regimens for frozen embryo transfer. ( Atkinson, M; Crittenden, J; Sjoblom, C; Smith, H, 2021) |
| "This study investigated the efficacy of GnRH agonists concomitantly with transient aromatase inhibitor and tranexamic acid to treat women with uterine arteriovenous malformations (AVMs) associated with abnormal uterine bleeding (AUB) to preserve fertility and determine reproductive outcome." | 3.91 | Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid. ( Abu-Rafea, B; Machado, M; Oraif, A; Vilos, AG; Vilos, GA, 2019) |
| "These results suggest that letrozole use may improve clinical pregnancy, clinical pregnancy with fetal heart beat, and live births and reduce the risk of miscarriage in patients undergoing single FET cycles." | 3.85 | Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles. ( Irahara, M; Jwa, SC; Kubota, T; Kuwahara, A; Saito, H; Tatsumi, T, 2017) |
| "There were no data on LBR or miscarriage with oral stimulation." | 2.82 | Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse. ( Bofill Rodriguez, M; Lumbiganon, P; Martins, WP; Salang, L; Solà, I; Sothornwit, J; Teixeira, DM, 2022) |
| "The occurrence of pregnancy, miscarriage and neonatal condition." | 2.74 | Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. ( Abdelhady, H; Allam, AF; Badawy, A; Shokeir, T, 2009) |
| "Letrozole (LE) has been found to improve the luteal function." | 1.91 | The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles. ( Chen, L; Gao, Y; Jiang, S; Kuang, Y; Long, H; Wang, Y; Xi, Q, 2023) |
| "8." | 1.91 | Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study. ( Cai, S; Gong, F; Guo, H; Li, X; Li, Y; Lin, G; Ma, S; Peng, Y; Tan, H; Tang, Y; Wang, X; Zhang, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 14 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, L | 1 |
| Li, RHW | 1 |
| Gemzell-Danielsson, K | 1 |
| Du, YH | 1 |
| Zhang, L | 1 |
| Diao, WY | 1 |
| Ho, PC | 1 |
| Atkinson, M | 1 |
| Crittenden, J | 1 |
| Smith, H | 1 |
| Sjoblom, C | 1 |
| Aramesh, S | 1 |
| Azizi Kutenaee, M | 1 |
| Najafi, F | 1 |
| Ghaffari, P | 1 |
| Taghavi, SA | 1 |
| Salang, L | 1 |
| Teixeira, DM | 1 |
| Solà, I | 1 |
| Sothornwit, J | 1 |
| Martins, WP | 1 |
| Bofill Rodriguez, M | 1 |
| Lumbiganon, P | 1 |
| Niu, Y | 1 |
| Zhao, D | 1 |
| Wang, Y | 2 |
| Suo, L | 1 |
| Zou, J | 1 |
| Wei, D | 1 |
| Franik, S | 2 |
| Le, QK | 1 |
| Kremer, JA | 2 |
| Kiesel, L | 2 |
| Farquhar, C | 2 |
| Wang, DD | 1 |
| Cao, JX | 1 |
| Jiang, WJ | 1 |
| Hou, JW | 1 |
| Yan, MH | 1 |
| Sun, ZG | 1 |
| Song, JY | 1 |
| Chen, L | 2 |
| Xi, Q | 1 |
| Jiang, S | 1 |
| Gao, Y | 1 |
| Long, H | 1 |
| Kuang, Y | 1 |
| Sunkara, SK | 1 |
| Kamath, MS | 1 |
| Pandian, Z | 1 |
| Gibreel, A | 1 |
| Bhattacharya, S | 1 |
| Wang, X | 2 |
| Li, Y | 1 |
| Tan, H | 1 |
| Cai, S | 1 |
| Ma, S | 1 |
| Peng, Y | 1 |
| Guo, H | 1 |
| Li, X | 1 |
| Tang, Y | 1 |
| Zhang, S | 1 |
| Lin, G | 1 |
| Gong, F | 1 |
| Shi, S | 1 |
| Hong, T | 1 |
| Jiang, F | 1 |
| Zhuang, Y | 1 |
| Huang, X | 1 |
| Huang, S | 1 |
| Hu, M | 1 |
| Ng, EHY | 1 |
| Stener-Victorin, E | 1 |
| Zheng, Y | 1 |
| Wen, Q | 1 |
| Wang, C | 1 |
| Lai, M | 1 |
| Li, J | 1 |
| Gao, X | 1 |
| Hu, Z | 1 |
| Xia, T | 1 |
| Hu, R | 1 |
| Liu, J | 1 |
| Wen, X | 1 |
| Li, S | 1 |
| Quan, K | 1 |
| Liang, X | 1 |
| Shang, H | 1 |
| Ma, H | 1 |
| Qiao, J | 1 |
| Glujovsky, D | 1 |
| Pesce, R | 1 |
| Sueldo, C | 1 |
| Quinteiro Retamar, AM | 1 |
| Hart, RJ | 1 |
| Ciapponi, A | 1 |
| Zeng, MF | 1 |
| Zhou, X | 1 |
| Duan, JL | 1 |
| Tatsumi, T | 2 |
| Jwa, SC | 2 |
| Kuwahara, A | 2 |
| Irahara, M | 2 |
| Kubota, T | 2 |
| Saito, H | 2 |
| Eltrop, SM | 1 |
| Vilos, AG | 1 |
| Oraif, A | 1 |
| Machado, M | 1 |
| Abu-Rafea, B | 1 |
| Vilos, GA | 1 |
| Eskew, AM | 1 |
| Bedrick, BS | 1 |
| Hardi, A | 1 |
| Stoll, CRT | 1 |
| Colditz, GA | 1 |
| Tuuli, MG | 1 |
| Jungheim, ES | 1 |
| Li, SJ | 1 |
| Zhang, YJ | 1 |
| Chai, XS | 1 |
| Nie, MF | 1 |
| Zhou, YY | 1 |
| Chen, JL | 1 |
| Tao, GS | 1 |
| Liu, A | 1 |
| Zheng, C | 1 |
| Lang, J | 1 |
| Chen, W | 1 |
| Badawy, A | 3 |
| Shokeir, T | 1 |
| Allam, AF | 1 |
| Abdelhady, H | 1 |
| Usadi, RS | 1 |
| Legro, RS | 1 |
| Al-Fozan, H | 1 |
| Al-Khadouri, M | 1 |
| Tan, SL | 1 |
| Tulandi, T | 1 |
| Mitwally, MF | 1 |
| Biljan, MM | 1 |
| Casper, RF | 1 |
| Abdel Aal, I | 1 |
| Abulatta, M | 1 |
| Mosbah, A | 1 |
| Shady, M | 1 |
| Noriega-Portella, L | 1 |
| Noriega-Hoces, L | 1 |
| Delgado, A | 1 |
| Rubio, J | 1 |
| Gonzales-Castañeda, C | 1 |
| Gonzales, GF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Administration of Single High Dose Letrozole for Ovulation Induction - A Randomized Controlled Trial[NCT02703649] | Phase 4 | 36 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary: A Randomized Controlled Trial[NCT03664050] | Phase 3 | 90 participants (Anticipated) | Interventional | 2018-01-01 | Recruiting | ||
| Efficacy of Combined Letrozole-metformin in Comparison With Letrozole Only in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome[NCT03135301] | Phase 3 | 80 participants (Anticipated) | Interventional | 2017-06-20 | Recruiting | ||
| Dosage Optimization for Letrozole Treatment in Clomiphene Resistant Patients With Polycystic Ovary Syndrome: A Prospective Interventional Study[NCT01315912] | Phase 4 | 44 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| A Multicenter Randomized Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth for Infertility in Women With Polycystic Ovary Syndrome[NCT03625531] | Phase 3 | 1,100 participants (Anticipated) | Interventional | 2018-08-13 | Recruiting | ||
| Intrauterine Insemination With Letrozole Versus Intrauterine Insemination in Natural Cycle. A Randomised Controlled Trial[NCT03455426] | 100 participants (Actual) | Interventional | 2018-03-15 | Completed | |||
| Letrozole Versus Laparoscopic Ovarian Drilling for Clomiphene-resistant Women With Polycystic Ovary Syndrome[NCT03009838] | Phase 3 | 150 participants (Anticipated) | Interventional | 2017-01-02 | Recruiting | ||
| Follicular Synchronization in Polycystic Ovarian Syndrome Patients Undergoing Intracytoplasmatic Sperm Injection With Letrozole /Antagonist Protocol: A Randomized Controlled Trial[NCT04069117] | Phase 4 | 200 participants (Actual) | Interventional | 2019-08-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for letrozole and Abortion, Spontaneous
| Article | Year |
|---|---|
Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.
Topics: Abortion, Spontaneous; Chorionic Gonadotropin; Clomiphene; Coitus; Female; Gonadotropin-Releasing Ho | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anovulation; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fema | 2022 |
In vitro fertilisation for unexplained subfertility.
Topics: Abortion, Spontaneous; Clomiphene; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadot | 2023 |
Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.
Topics: Abortion, Spontaneous; Bias; Clomiphene; Cryopreservation; Drug Administration Schedule; Embryo Impl | 2020 |
Stimulated cycle versus artificial cycle for frozen embryo transfer in patients with polycystic ovary syndrome: a Meta-analysis.
Topics: Abortion, Spontaneous; Aromatase Inhibitors; Cryopreservation; Embryo Implantation; Embryo Transfer; | 2021 |
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Anastrozole; Aromatase Inhibitors; Birth Rate; Clomiphene; Coitus; Female; Fe | 2018 |
Letrozole Compared With Clomiphene Citrate for Unexplained Infertility: A Systematic Review and Meta-analysis.
Topics: Abortion, Spontaneous; Aromatase Inhibitors; Clomiphene; Estradiol; Female; Fertility Agents, Female | 2019 |
Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Bias; Clomiphene; Endometrium; Estradiol; Female; Follicle Stimulating Hormon | 2014 |
Reproductive impact of polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Clomiphene; Female; Fertilization in Vitro; Humans; Infant, Newborn; Infertil | 2012 |
9 trials available for letrozole and Abortion, Spontaneous
| Article | Year |
|---|---|
Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Letrozole; Mifepristone; Misoprostol; Preg | 2022 |
Granulocyte colony stimulating factor (GCSF) did not affect the fertility outcomes in women with unexplained infertility after intrauterine insemination: a randomised clinical trial.
Topics: Abortion, Spontaneous; Clomiphene; Cytokines; Female; Fertility; Granulocyte Colony-Stimulating Fact | 2022 |
Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study.
Topics: Abortion, Spontaneous; Adult; Clomiphene; Endometrium; Estradiol; Female; Humans; Infertility, Femal | 2020 |
A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Acupuncture Therapy; Aromatase Inhibitors; Female; Humans; Infertility, Femal | 2020 |
Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer.
Topics: Abortion, Spontaneous; Adult; Aromatase Inhibitors; Birth Rate; Case-Control Studies; China; Cryopre | 2014 |
Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility.
Topics: Abortion, Spontaneous; Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Female; Fertility Agent | 2009 |
A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation.
Topics: Abortion, Spontaneous; Adult; Aromatase Inhibitors; Clomiphene; Endometrium; Female; Fertility Agent | 2004 |
RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial.
Topics: Abortion, Spontaneous; Adult; Aromatase Inhibitors; Clomiphene; Dose-Response Relationship, Drug; En | 2009 |
RETRACTED: Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.
Topics: Abortion, Spontaneous; Adult; Anastrozole; Aromatase Inhibitors; Clomiphene; Drug Resistance; Endome | 2008 |
10 other studies available for letrozole and Abortion, Spontaneous
| Article | Year |
|---|---|
Retrospective cohort study on preparation regimens for frozen embryo transfer.
Topics: Abortion, Spontaneous; Cryopreservation; Embryo Transfer; Female; Follicle Stimulating Hormone; Huma | 2021 |
Ovulation induction regimens are associated with a higher rate of livebirth after frozen single-blastocyst transfer among women with polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Embryo Transfer; Female; Humans; Infant, Newborn; Letrozole; Menotropins; Ovu | 2022 |
Comparison of pregnancy outcomes of letrozole-induced frozen-thawed embryo transfer cycles in PCOS women with two different abnormal ovulation patterns: A retrospective cohort study.
Topics: Abortion, Spontaneous; Embryo Transfer; Female; Humans; Letrozole; Ovulation; Ovulation Induction; P | 2023 |
The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles.
Topics: Abortion, Spontaneous; Chorionic Gonadotropin; Female; Fertilization in Vitro; Gonadotropin-Releasin | 2023 |
Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study.
Topics: Abortion, Spontaneous; Adult; Cohort Studies; Cryopreservation; Diabetes, Gestational; Embryo Transf | 2023 |
Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles.
Topics: Abortion, Spontaneous; Aromatase Inhibitors; Blastocyst; Cohort Studies; Cryopreservation; Female; F | 2017 |
Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Topics: Abortion, Spontaneous; Adult; Antifibrinolytic Agents; Aromatase Inhibitors; Arteriovenous Fistula; | 2019 |
No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Aromatase Inhibitors; Female; Fertilizati | 2017 |
Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation.
Topics: Abortion, Spontaneous; Aromatase Inhibitors; Cohort Studies; Female; Humans; Letrozole; Nitriles; Ov | 2005 |
Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Topics: Abortion, Spontaneous; Adult; Aromatase Inhibitors; Chorionic Gonadotropin; Cost-Benefit Analysis; D | 2008 |